Tiger Pharmaceuticals announced that the company's actual controllers, Ye Xiaoping and Cao Xiaochun, received a warning letter and advance notice of administrative penalties issued by the Zhejiang Regulatory Bureau. The two were taken to issue a warning letter and recorded in the integrity file due to a 1% reduction in total equity changes in their active shareholding ratio in December 2022; in addition, due to a 5% change in total shareholding ratio in September 2019 and not promptly disclosing the simplified equity change report, the Zhejiang Supervisory Authority plans to warn the two, with a total fine of 1 million yuan, of which Ye Xiaoping and Cao Xiaochun were each fined 500,000 yuan. The above matters have nothing to do with the company's operations; they do not touch on major illegal forced delisting or other risk warning situations; the company's production and operation are normal.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.